SK Bioscience Co (XKRX:302440) Short-Term Capital Lease Obligation : ₩6,074 Mil (As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Short-Term Capital Lease Obligation?

SK Bioscience Co's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩6,074 Mil.

SK Bioscience Co's quarterly Short-Term Capital Lease Obligation declined from Mar. 2024 (₩9,264 Mil) to Jun. 2024 (₩7,712 Mil) and declined from Jun. 2024 (₩7,712 Mil) to Sep. 2024 (₩6,074 Mil).

SK Bioscience Co's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (₩2,309 Mil) to Dec. 2022 (₩12,235 Mil) but then declined from Dec. 2022 (₩12,235 Mil) to Dec. 2023 (₩8,137 Mil).

SK Bioscience Co Short-Term Capital Lease Obligation Historical Data

The historical data trend for SK Bioscience Co's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Short-Term Capital Lease Obligation Chart

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

1,350.76

1,613.60

2,309.26

12,234.53

8,137.40

SK Bioscience Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															10,038.03	8,137.40	9,264.36	7,712.05	6,074.49

SK Bioscience Co Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

SK Bioscience Co Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co Headlines

No Headlines